References

117

References Ait-Si-Ali S, Guasconi v, Fritsch L, Yahi H, Sekhri R, Naguibneva I, Robin P, Cabon F, Polesskaya A. and Harel-Bellan A. (2004). A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells. Embo J 23: 605-615.

Allis CD, Berger SL, Cote J, Dent S, Jenuwien T, Kouzarides T, Pillus L, Reinberg D, Shi Y, Shiekhattar R, et al. (2007) New nomenclature for chromatin modifying enzymes. Cell 131: 633-6j6.

'I

Andres V and Walsh K. (1996). Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell BioI 132: 657-66.

Sadri KR, Zhou Y, Dhru U, Armagam Sand Schuger L. (2008). Tension Induced/inhibited Proteins (TIPs) are novel partners of the histone acetyltransferase p300: TIPs SANT domain in p300 activity and TIP-6-induced adipogenesis. Mol Cell BioI 28: 6358-6372.

Baserga, R Costlow, M and Rovera, G. (1973). Changes in membrane function and chromatin template activity in diploid and transformed cells in culture. Fed Proc 32: 2115-2118.

Beauchamp JR, Heslop L, Yu DSW, Tajbakhsh S, Kelly RG, Wernig A, Buckingham ME, Partridge TA and Zammit PS. (2000). Expression of CD34 and Myf5 defines the majority defines the majority of quiescent adult skeletal muscle satellite cells. J Cell BioI 151: 1221-1234.

Beisel C, Imhof A, Greene J, Kremmer E. and Sauer F. (2002). Histone methylation by the Drosophila epigenetic transcriptional regulator Ash1. Nature 419: 857-862.

Blanchard, J.-M. (2000). Cyclin A2 transcriptional regulation: modulation of cell -cycle control at the G1/S transition by peripheral cues. Biochem Pharmacol 60: ' 1179-1184.

Blau HM, Chiu C.-P. and Webster C. (1983). Cytoplasmic activation of human nuclear genes in stable heterocaryons. Cell 32: 1171-1180.

Brehm A, Miska E A, McCance D J, Reid J L, Bannister AJ. and Kouzarides T. (1998). Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391: 597-601.

Buckingham M. (1992). Making muscle in mammals. Trends Genet 8: 144-148.

118

Buckingham M. (2001). Skeletal muscle formation in vertebrates. Curr Opin Genet Dev 11: 440-448.

Burstin SJ, Meiss HK and Basilico C. (1974). A temperature-sensitive cell cycle mutant of the BHK cell line. J Cell Physio/84: 397-408.

Carnac G, Fajas L, -L'Honore A, Sardet C, Lamb NJC, and Fernandez A. (2000). The retinoblastoma -like protein p130 is involved in the determination of reserve cells in differentiation. Current Biology 10: 543-546.

Cheng F, Liu J, Zhou SH, Wang XN, Chew JF and Deng, LW. (2008). RNA interference against mixed lineage leukemia 5 resutrncrin cell cycle arrest. Int J Biochem Cell BioI 40: 2472-2481.

Christov C, Chretien F, Abou-Khalil R, B'pssez G, Vallet G, Authier F.-J, Bassaglia Y, Shinin V, Tajbakhsh S, Chazaud, B and Gherardi RK. (2007). Muscle Satellite Cells and Endothelial Cells: Close Neighbors and Privileged Partners. Mol BioI Cell 18: 1397-1409.

Clegg CH, Linkhart TA, Olwin BB §lnd Hauschka SO (1987) Growth factor control of skeletal muscle differentiation: commitment to terminal differentiation occurs in G1 phase. J Cell BioI 1 05: 949-956.

Coisy M, Roure V, Ribot M, Philips A, Muchardt C, Blanchard J-M, & Dantonel J-C. (2004). Cyclin A expression in quiescent cells is associated with chromatin remodeling of its promoter and requires Brahma/SNF2 Alpha. Molecular Cell 15: 43-56.

Coisy-Quivy M, Disson 0, Roure V, Muchardt C, Blanchard J-M, & .. Dantonel J-C. (2006). Role of BRM in cell growth control. Cancer Res 66: 5069-5076.

Coller, A.H. (2007). What's taking so long? S phase entry from quiescence versus proliferation. Nat Rev Mol Cell BioI 8: 667-670.

Collins CA. (2006) Satellite cell selfrenewal. Curr Opin Pharmaco/6: 301-306.

Collins N, Poot RA, Kukimoto I, Garcia-Jimenz C, Dellaire G, Varga- .Yaiz PD .. (2002). An ACF1-ISWI chromatin-remodeling complex is required for DNA replication through heterochromatin Nat Genet 32: 627-632.

Coppock DL, Kopman C, Scandalis S and Gilleran S. (1993).Preferential gene expression in quiescent human lung fibroblasts. Cell Growth Differ 4: 483-493.

Cornelison, DD a~Wold BJ. (1997). Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev Bioi 191: 270-83.

119

Cossu G, ~Borello U. (1999) Wnt signaling and activation of myogenesis in mammals~ EMBO J 18: 6867-6872.

Cossu G, Kelly R, Tajbakhsh S, DiDonna S, Vivarelli E and Buckingham M. (1996). Activation of different myogenic pathways: Myf5 is induced by neural tube and MyoD by the dorsal 'ectoderm in paraxial mesoderm. Development 122: 429-437.

Coverley D, Lamen H and Laskey AR. (2002). Distinct roles for Cyclin E and A during DNA replication complex assembly and activation. Nat Cell Bioi 4: 523-528.

Dahiya A, Wong S, Gonzalo S,. Gavin ~M, Dean DC. (2001). Linking the Rb and polycomb pathways. Mol cell 8: 557-569. - .

Daser A, Rabbitts TH. (2004). Extending the repertoire of the mixed-lineage leukemia gene MLL in leukemogenesis. Genes Dev 18: 965-74.

Davis RL, Weintraub H, & Lassar AB (1987) Expression of a single transfectedJ r;. "\ cDNA converts fibroblasts to myoblasts. Cell 51: 987-1000.

De Angelis L, Berghella L, Coletta M, Lattanzi L, Zanchi M, Gabriella MC, Ponzetto C, and Cossu G. (1999). Skeletal Myogenic progenitors originating from embryonic dorsal aorta coexpress endothelial and myogenic markers and contribute to postnatal Muscle growth and regeneration J Cell Bioi 147: 869-878.

Debril MB, Gelman L, Fayard E, Annicotte JS, Rocchi Sand Auwerx J. (2004). Transcription factors and nuclear receptors interact with the SWI/SNF complex through the BAF60c subunit. J Bioi Chern 279: 16677-16686.

de la Serna IL, Carlson AK and Imbalzano AN. (2001 B). Mammalian SWI/SNF complex promote MyoD mediated muscle differentiation. Nat Genet 27: 187-190.

de la Serna IL, Ohkawa Y, Berkes CA, Bergstrom DA, Dacwag CS, Tapscott SJ and Imbalzano AN. (2005). MyoD targets chromatin remodeling complexes to the myogenin locus prior to forming a stable DNA-bound complex. Mol Cell Bioi 25: 3997-4009.

de la Serna IL, Ohkawa Y and Imbalzano AN. (2006). Chromatin remodelling in mammalian differentiation: lessons from ATP dependent remodelers. Nature Rev Genet 7: 461-473.

de la Serna IL, Roy K, Carlson KA and Imbalzano AN. (2001A). MyoD can induce cell cycle arrest but not muscle differentiation in the presence of dominant negative SWI/SNF chromatin remodeling enzymes. J Bioi Chern 276: 41486-41491.

120

Del-Sal G, Ruaro ME, Philipson L, and Schneider C. (1992). The growth arrest-specific gene, gas1, is involved in growth suppression. Cell 70: 595-607.

Deng L-W, Chiu I and Strominger JL. (2004). MLL 5 protein forms intranuclear foci, and overexpression inhibits cell cycle progression. Proc Nat! Acad Sci USA 101: 757-762.

Dhawan J and Helfman DM. (2004). Modulation of acto-myosin contractility in skeletal muscle myoblasts uncouples growth arrest from differentiation J Cell Sci 117: 3735-3748.

Dhawan J, Rando TA (2005)& Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation & replenishment. Trends Cell BioI 15: 666-673.

Dou Y, Milne AT, Ruthenburg JA, Lee S, Lee WJ, Verdine LG, Aliis DC and Roeder GR. (2006). Regulation of MLL 1 H3K4 methyl transferase activity by its core components. Nat Structure 13: 713-719.

Emerling 8M, Bonifas J, Kratz CP, Donovan S, Taylor BR, Green ED, Le Beau MM and Shannon KM. (2002). MLL5, a homolog of Drosophila trithorax located within a segment of chromosome band 7q22 implicated in myeloid leukemia. Oncogene 21: 4849-4854.

Endo T and Nadal-Ginard B. (1998). Reversal of myogenic terminal differentiation by SV40 large T antigen results in mitosis and apoptosis. J Cell Sci 111: 1081-1093.

Fackler MJ, Krause DS, Smith OM, Civin CI and. May WS. (1995). Full-length but not truncated CD34 inhibits hematopoietic cell differentiation of M1 cells. Blood 85: 3040-3047.

Feinberg AP and B Vogelstein. 1984. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Addendum Anal Biochem 137: 266-267.

Giacinti C and Giordano A. (2006). RB and cell cycle progression. Oncogene 25: 5220-5227.

Gillespie M A and Rudnicki M A (2004). Something to SNF about. Nature Genetics 36: 676-677.

Girard F, Strausfeld U, Fernandez A and Lamb NJC. (1991). Cyclin A is required for the onset of DNA replication in mammalian fibroblasts. Cell 67: 1169-1179.

121

Gopinath SO, Narumiya Sand Dhawan J. (2007). The RhoA effector mDiaphanous regulates MyoD expression and cell cycle progression via SRF-dependent and SRF-independent pathways. J Cell Sci 120: 3086-3098.

Goto H, Tomono Y, Ajiro K, Kosako H, Fujita M, Sakurai M, Okawa K, Iwamatsu A, Okigaki T, Takahashi T, et al. (1999) Identification of a novel phosphorylation site on Histone H3 coupled with mitotic chromosome condensation. J BioI Chern 274: 25543-25549.

Grigoryev SA, Nikitina T, Pehrson JR, Singh PB, Woodcock CL. (2004) Dynamic relocation of epigenetic chromatin marksers reveals an active role of constitutive heterochromatin in the transition from proliferation to quiescence. J Cell Sci 117: 6153-6162.

Grounds MD. (1991). Towards understanding skeletal muscle regeneration. Pathol Res Pract 187: 1-22.

Halevy 0, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach 0 and Lassar AB. (1995). Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267: 1018-1021.

Heuser M, Yap DB, Leung M, de Algara TR, Tafech A, McKinney S, Dixon J, Thresher R, Colledge B, Carlton M, Humphries RK and ApariCio SA. (2009). Loss of MLL5 results in pleiotropic hematopoietic defects, reduced neutrophil immune function, and extreme sensitivity to DNA demethylation. Blood 113: 1432-1443.

Huet X, Rech J, Plet A, Vie A and Blanchard JM. (1996). Cyclin A expression is under negative transcriptional control during the cell cycle. Mol. Cell. BioI. 16: 3789-3798.

Irintchev A, Zeschnigk M, Starzinski-Powitz A, Wernig A. (1994). Expression pattern of M-cadherin in normal, denervated, and regenerating mouse muscles. Oev Oyn 199: 326-37.

Jenuwein T. (2006) The epigenetic magic of histone lysine methylation. FEBS J 273:3121-35.

Kadam 5 and Emerson BM. (2003) Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol Cell. 11: 377-389.

Katsuno Y, Suzuki A, Sugimura K, Okumura K, Zineldeen DH, Shimada M, Niida H, Mizuno T, Hanaoka F, and Nakanishi M. (2009). Cyclin A-Cdk1 regulates the origin firing program in mammalian cells. Proc Nat! Acad Sci USA (In press).

122

Kittler R, Pelletier L, Heninger A-K, Siabicki M, Theis M, Miroslaw L, Poser I, Lawo S, Grabner H, Kozak K, et al. (2007). Genome-scale RNAi profiling of cell division in human tissue culture cells Nat Cell Bioi 9: 1401-1412.

Kouzarides T (2007). Chromatin Modifications and Their Function. Cell 128: 693-705

Krause 05, Fackler MJ, Civin CI, and May WS. (1996). CD34: structure, biology, and clinical utility. Blood 87: 1-13.

Kuang 5 and Rudnicki M A. (2007). The emerging biology of satellite cells and their therapeutic potential. Trends Mol Med 14: 82-91.

Kunag 5, Kuroda K, LeGrand F, Rudnicki M A. (2007) Assymetric self renewal and commitment of satellite stem cells in muscle. Cell 129: 999-1010.

LaBarge MA and Blau HM. (2002). Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell 111: 589-601.

Laemmli UK. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680-685.

Lassar AB, Skapek SX, Novitch B. (1994). Regulatory mechanisms that co-ordinate skeletal muscle differentiation and cell cyle withdrawal. Curr Opin Cell Bioi. 6: 788-794.

LeGrand F and Rudnicki MA. (2007). Skeletal muscle satellite cells and adult myogenesis. Curr Opin Cell Bioi 19: 628-633.

Liu H, Westergard TO and Hsieh JJD. (2009). MLL5 governs hematopoiesis: a step closer. Blood 113: 1395-1396.

Loyola A and Almouzni G (2007). Marking Histone variants: How, when and why? Trends Biochem Sci32:425-434

Lujvidin 5, Fuchs 0, Nudel U and Yaffe D. (1990). SV40 immortalizes myogenic cells: DNA synthesis and mitosis in differentiating myotubes. Differentiation 43: 192-203.

Luo RX, Postigo AA, and Dean DC. (1998). Rb interacts with histone deacetylase to repress transcription. Cell 92: 463-73.

Madan V, Madan B, Brykczynska U, Zilbermann F, Hogeveen K, Dohner K, Dohner H, Weber 0, Blum C, Rodewald H.-R, Sassone-Corsi P, Peters AHFM, and Fehling

123

HJ. (2009). Impaired function of primitive hematopoietic cells in mice lacking the Mixed-lineage-Leukemia homolog M1I5. Blood 113: 1444-1454.

Magenta A, Cenciarelli C, De Santa F, Fuschi P, Martelli F, Caruso M and Felsani A .(2003). MyoD Stimulates RB Promoter Activity via the CREB/p300 Nuclear Transduction Pathway. Mol Cell BioI 23: 2893-2906.

Mal A, Chattopadhyay D, Ghosh MK, Poon RYC, Hunter T and Harter ML. (2000). p21 and retinoblastoma protein control the absence of DNA replication in terminally differentiated muscle cells. J Cell BioI 149: 281-292.

Mal A and Harter ML. (2003). MyoD is functionally linked to the silencing of a muscle-specific regulatory gene prior to skeletal myogenesis. Proc Natl Acad Sci U SA 100: 1735-1739.

Mal A, Sturniolo M, Schiltz RL, Ghosh MK and Harter ML. (2001). A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program. Embo J 20: 1739-1753.

Martin RG and Stein S. (1976). Resting state in normal and simian virus 40 transformed Chinese hamster lung cells. Proc. Nat! Acad. Sci. USA 73: 1655-1659.

Mauro A. (1961). Satellite cell of skeletal muscle fibers. J Biophys Biochem Cyto/9: 493-495.

McCroskery S, Thomas M, Maxwell L, Sharma M, and Kambadur R. (2003). Myostatin negatively regulates satellite cell activation and self-renewal. J Cell BioI 162:1135-1147.

McFarlane C, Hennebry A, Thomas M, Plummer E, ling N, Sharma M, and Kambadur R. (2008). Myostatin signals through Pax7 to regulate satellite cell self-renewal. Exp Cell Res 314:317-329.

McKinnell IW, Ishibashi J, Le Grand F, Punch VG, Addicks GC, Greenblatt JF, Dilworth FJ, Rudnicki MA. (2008) Pax7 activates myogenic genes by recruitment of a histone methyltransferase complex. Nat Cell BioI 1 0: 77-84.

Mellor J (2006). It takes a PHD to read the histone code. Cell 126: 22-24.

Mendelsohn ML. (1962) Autoradiographic analysiS of cell proliferation in spontaneous breast cancer of C3H mouse. III. The growth fraction. J Natl Cancer Inst. 28: 1015-1029.

Milasincic OJ, Dhawan J and Farmer SR. (1996). Anchorage-dependent control of muscle-specific gene expression in C2C 12 mouse myoblasts. In Vitro Cell Dev BioI Anim 32: 90-99.

124

Miller JB. (1990). Myogenic programs of mouse muscle cell lines: expression of myosin heavy chain isoforms, MyoD1, and myogenin. J. Cell BioI. 111: 1149-1159.

Nakamura T, Mori T, Tada S, Krajewski W, Rozovskaia T, Wassell R, Dubois G, Mazo A, Croce CM, Canaani E. (2002). ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol Cell 10:1119-1128.

Neilsen SJ, Schneider R, Bauer UM, Bannister AJ, Morrison A, O'Carroll D, Firestein R, Cleary M, Jenuwein T, Herrera RE, Kouzarides T. (2001) Rb targets histone H3 methylation and HP1 to promoters. Nature 412: 561-565.

Ng RK. and Gurdon, JB. (2008) Epigenetic inheritance of cell differentiation status Cell Cycle 7: 1173-1177.

Ng RK and Gurdon JB. (2008). Epigenetic memory of an active gene state depends on histone H3.3 incorporation into chromatin in the absence of transcription. Nat Cell BioI 10: 102-109.

Nightingale KP, Gendreizig S, White DA, Bradbury C, Hollfelder F and Turner BM. (2007). Cross-talk between Histone Modifications in Response to Histone Deacetylase Inhibitors: MLL 4 links Histone H3 acetylation and histone H3K4 methylation. J BioI Chern 282: 4408-4416.

Novitch BG, Mulligan GJ, Jacks T, and Lassar AB. (1996). Skeletal muscle cells lacking the retinoblastoma protein display defects in muscle gene expression and accumulate in Sand G2 phases of the cell cycle. J Cell BioI 135: 441-456.

Ogawa H, Ishiguro K.-i, Gaubatz S, Livingston DM and Nakatani Y. (2002). A Complex with Chromatin Modifiers That Occupies E2F- and Myc-Responsive Genes in GO Cells. Science 296: 1132-1136.

Ohkawa Y, Marfella CGA, Imbalzano AN. (2006). Skeletal muscle specification by myogenin and Mef2D via the SWIISNF ATPase Brg1. EMBO J 25: 490-501.

Ohkawa Y, Yoshimura S, Higashi C, Marfella CGA, Dacwag C, and Imbalzano AN. (2007). Myogenin and the SWI/SNF ATPase Brg1 maintain myogenic gene expression at different stages of skeletal myogenesis. J BioI Chern 282: 6564-6570.

Olguin He and Olwin BB. (2004). Pax-7 up-regulation inhibits myogenesis & cell cycle progression in satellite cells: a potential mechanism for self-renewal Dev BioI 275: 375-388.

Olson EN. (1992). Interplay between proliferation and differentiation within the myogenic lineage. Oev BioI 154: 261-272.

125

Ordahl CP, Williams BA, Denetclaw W. (2000). Determination and morphogenesis in myogenic progenitor cells: an experimental embryological approach. Curr Top Dev BioI. 48: 319-67.

Pardee AB. (1974). A restriction point for control of normal animal cell proliferation. Proc Nat! Acad Sci USA 71: 1286-1290.

Passegue E and Wagers AJ. (2006). Regulating Quiescence: New Insights into Hematopoietic Stem Cell Biology. Dev Cell 10: 415-417.

Pirskanen A, Kiefer JC and Hauschka SO. (2000). IGFs, Insulin, Shh, bFGF, and TGF-~1 interact synergistically to promote somite myogenesis in vitro. Dev BioI 224: 189-203.

Planas-Silva MD and Weinberg RA. (1997). The restriction pOint and control of cell proliferation. Curr Opin Cell BioI 9: 768-772.

Polesskaya A, Naguibneva I, Fritsch L, Duquet A, Ait-Si-Ali S, Robin P, Vervisch A, Pritchard LL, Cole P and Harel-Bellan A (2000). CBP/p300 and muscle differentiation: no HAT, no muscle. Embo J 20: 6816-25.

Polyak K, Kato JY, Solomon MJ, Sherr CJ, Massague J, Roberts JM and Koff A. (1994) p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes dev 8: 9-22.

Puri KD, Finger EB, Gaudernack G, and Springer TA. (1995). Sialomucin CD34 is the major L-selectin ligand in human tonsil high endothelial venules. J Cell BioI 131 : 261-70.

Puri PL, Avantaggiati ML, Balsano C, Sang N, Graessmann A, Giordano A, Levrero M. (1997A). p300 is required for MyoD-dependent cell cycle arrest and muscle-specific gene transcription. EMBO J 16: 369-83.

Puri PL, Iezzi S, Stiegler P, Chen TT, Schiltz LR, Muscat GE, Giordano A, Kedes L,. Wang JY, and Sartorelli V. (2001). Class I histone deacetylases sequentially interact with MyoD and pRb during skeletal myogenesis. Mol Cell 8: 885-897.

Puri PL, Medaglia S, Cimino L, Maselli C, Germani A, De Marzio E, Levrero M, Balsano C.(1997B). Uncoupling of p21 induction and MyoD activation results in the failure of irreversible cell cycle arrest in doxorubicin-treated myocytes. J Cell Biochem 66: 27-36

Puri PL and Sartorelli V. (2000). Regulation of muscle regulatory factors by DNA-binding, interacting proteins, and post-transcriptional modifications. J Cell Physiol 185: 155-73.

126

Puri PL, Sartorelli V, Yang XJ, Hamamori Y, Ogryzko W, Howard BH, Kedes L, Wang JY, Graessmann A, Nakatani Y, Levrero M. (1997C) .A. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol Cell 1 : 35-45.

Rampalli 5, Li L, Mak E, Ge K, Brand M, Tapscott SJ, Dilworth FJ. (2007). p38 MAPK signaling regulates recruitment of Ash2L-containing methyltransferase complexes to specific genes during differentiation. Nat Struct Mol BioI. 14: 1150-1156.

Rayman JB, Takahashi Y, Indjeian VB, Dannenberg JH, Catchpole S, Watson RJ, Teriele Hand Dynlacht BD. (2002). E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. Genes Dev 16: 933-947.

Rea 5, Eisenhaber F, 0 carroll D, Strahl BD, Sun Z, Opravil S, Mechtler K, Ponting CP, Allis CD and Jenuwein T. (2000). Regulation of chromatin structureby site specific histone 3 methyltransferase. Nature 406: 593-599.

Reddy G et al. (2004) Onset of DNA synthesis & S phase in Cell Cycle & Growth Control. Stein GS & Pardee AB (Wiley) pp 149-200.

Relaix F, Rocancourt D, Manosouri A and Buckingham, M. (2005). A Pax3 Pax7 dependent population of skeletal muscle progenitor cells. Nature 435: 948-53.

Ruthenburg AJ, Allis CD and Wysocka J (2007) Methylation of Lysine 4 on Histone H3: Intricacy of Writing and Reading a Single Epigenetic Mark. Mol Cell 25: 15-30.

5achidanandan C and Dhawan J. (2003). Skeletal muscle progenitor cells in Development and regeneration. Proc. Indian nat! Sci Acad 69: 719-740.

5achidanandan C, Sambasivan R, and Dhawan J. (2002). Tristetraprolin and LPS-inducible CXC chemokine are rapidly induced in presumptive satellite cells in response to skeletal muscle injury. J Cell Sci 115: 2701-2712.

5ambasivan R, Pavlath GK, and Dhawan J. (2008). A gene-trap strategy identifies quiescence induced genes in synchronized myoblasts. J Biosci 33: 27-44

5ansregret L, Goulet B, Harada R, Wilson B, Leduy L, Bertoglio J and Nepveu A. (2006). The p11 0 isoform of the CDP/Cux transcription factor accelerates entry into S phase. Mol Cell BioI 26 : 2441-2455.

5antaguida M and Nepveu A (2005) Differential Regulation of CDP/Cux p110 by Cyclin A/Cdk2 and Cyclin A/Cdk1. J BioI Chern 280: 32712-32721.

127

Santos-Rosa H, Schneider R, Bernstein BE, Karabetsou N, Morillon A, Weise C, Schreiber SL, Mellor J, Kouzarides T. (2003) Methylation of histone H3 K4 mediates association of the Isw1 p ATPase with chromatin. Mol Ge1/12: 1325-133.

Schneider C, King RM and Philipson L. (1988). Genes specifically expressed at growth arrest of mammalian cells. Gel/54: 787-793.

Schultz E (1976). Fine structure of satellite cells in growing skeletal muscle. Am J Anat 147: 49-70.

Schultz E, McCormick KM. (1994). Skeletal muscle satellite cells. Rev Physiol Biochem Pharmecol. 123: 213-57

Seale P and Rudnicki MA. (2000B). A new look at the origin, function, and "stem-cell" status of muscle satellite cells. Dev BioI 218: 115-124.

Seale P, Sabourin LA, Girgis-Gabardo A, Mansouri A, Gruss P, and. Rudnicki MA. (2000A). Pax7 is required for the specification of myogenic satellite cells. Ge1l102: 777-786.

Seale P, Bjork B, Yang W, Kajimura S, Chin S, Kuang S, Scime A, Devarakonda S, Conroe HM, Erdjument-Bromage H st al. (2008). PRDM16 controls a brown fat/skeletal muscle switch. Nature 454: 961-967.

Sebastian S, Sreenivas P, Sambasivan R, Cheedipudi S, Kandalla P, Pavlath GK and Dhawan J. (2009). MLL5, a trithorax homolog indirectly regulates H3K4 methylation, represses Cyclin A2 expression and promotes myogenic differentiation. Proc Nat! Acad Sci USA (in press)

Sherr JC and Roberts MJ. (2004) Living with or without cyclins and cyclin dependent kinases. Genes Dev 18: 2699-2711.

Shi X, Hong T, Walter KL, Ewalt M, Michishita E, Hung T, Carney D, Peria P, Lan F, Kaadige MR, Lacoste N, Cayrou C, Davrazou F, Saha A, Cairns BR, Ayer DE, Kutateladze TG, Shi Y, Cote J, Chua KF, Gozani O. (2006). ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature.442: 96-99.

Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA and Shi Y. (2004). Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1. Ge1l119: 941-953.

Sierra J, Yoshida T, Joazeiro CA, Jones KA. (2006) The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at wnt target genes. Genes Dev. 20: 586-600.

128

Simone C, Forcales SV, Hill DA, Imbalzano AN, Latella Land Puri PL. (2004). p38 pathway targets SWI-SNF chromatin-remodeling complex to muscle-specific loci. Nat Genet 36: 738-743.

Smith CK, Janney MJ and Allen RE. (1994). Temporal expression of myogenic regulatory genes during activation, proliferation, and differentiation of rat skeletal muscle satellite cells. J Cell Physio/159: 379-385.

Smith JA and Martin, L. (1973). Do cells cycle? Proc. Natl Acad. Sci. USA 70: 1263-1267.

Stevaux O. and. Dyson N.J. (2002). A revised picture of the E2F transcriptional network and RB function. CUff Opin Cell BioI 14: 684-691.

Takahashi V, Rayman JB, and Dynlacht BD. (2000). Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression. Genes Dev 14: 804-816.

Takeda 5, Chen DV, Westergard TD, Fisher JK, Rubens JA, Sasagawa S, Kan JT, Korsmeyer SJ, Cheng EHV and Hsieh JJD. (2006). Proteolysis of MLL family proteins is essential for Taspase1-orchestrated cell cycle progression. Genes Dev 20: 2397-2409.

Tapscott SJ. (2005). The Circuitry of a master switch: Myod and the regulation of skeletal muscle gene transcription. Development 132: 2685-2695.

Tatsumi R, Anderson JE, Nevoret CJ, Halevy 0, and Allen RE. (1998). HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev BioI 194: 114-28.

Van-Dijk K, Marley KE, Jeong Br, Xu J, Hesson J, Cerny RL, Waterborg JH and Cerutti H .(2005) Monomethyl Histone H3 Lysine 4 as an Epigenetic Mark for Silenced Euchromatin in Chlamydomonas. Plant Cell 17: 2439-2453.

Walsh K and Perlman H (1997) Cell cycle exit upon myogenic differentiation. CUff Opin Genet Dev 7: 597-602.

Weintraub H. (1993) The MyoD family and myogenesis: redundancy, networks, and thresholds Cell 75: 1241-1244.

Wei Q and Paterson BM. (2001). Regulation of MyoD function in the dividing myoblast. FEBS Letter 490: 171-178.

Wu JR and Gilbert DM. (1996). A distinct G1 step required to specify the Chinese hamster DHFR replication origin. Science 271: 1270-1272.

129

Xiao 8, Jing C, Wilson JR, Walker PA, Vasisht N, Kelly G, Howell S, Taylor lA, Blackburn GM and Gamblin SJ. (2003). Structure and catalytic mechanism of the human histone methyltransferase SET7/9. Nature 421: 652-656.

Yaffe D. and Saxel O. (1977). A myogenic cell line with altered serum requirements for differentiation. Differentiation 7:159-166.

Yokoyama A, Wang Z, Wysocka J, Sanyal M, Aufiero DJ, Kitabayashi I, Herr W, and Cleary ML. (2004). Leukemia Proto-Oncoprotein MLL Forms a SET1-Like Histone Methyltransferase Complex with Menin To Regulate Hox Gene Expression Mol Cell BioI 24: 5639-5649.

Yoshida N, Yoshida S, Koishi KK Masuda and Nabeshima Y. (1998). Cell heterogeneity upon myogenic differentiation: down-regulation of MyoD and Myf-5 generates 'reserve cells'. J Cell Sci 111: 769-79.

Yu JY, DeRuiter SL and Turner DL .(2002). RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Nat! Acad Sci U SA 99: 6047-6052.

Zhang JM, Wei Q, Zhao X, and Paterson BM. (1999A). Coupling of the cell cycle and myogenesis through the Cyclin D1-dependent interaction of MyoD with CDK4. Embo J 18: 926-933.

Zhang JM, Zhao X, Wei Q, and Paterson HM. (1999B).A. Direct inhibition of G(1) cdk kinase activity by MyoD promotes myoblast cell cycle withdrawal and terminal differentiation. Embo J 18: 6983-93.

Zhang SH, Gavin M, Dahiya A, Postigo AA, Ma D, Luo XR, Harbour WJ and Dean CD. (2000). Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb -hSWIISNF and Rb-hSWIISNF. Cell 101: 71-89.

Zhang Y, Wong J, Klinger M, Tran MT, Shannon KM and Killeen N. (2009). MLL5 contributes to hematopoietic stem cell fitness and homeostasis. Blood 113: 1455-1463.

Zhou J, Chau CM, Deng Z, Shiekhattar R, Spindler MP, Schepers A, Lieberman PM. (2005). Cell cycle regulation of chromatin at an origin of DNA replication. EMBO J 24:1406-1417.

Zitlerberg A and Larsson O. (1985). Kinetic analysis of regulatory events in G1 leading to proliferation or quiescence of Swiss 3T3 cells. Proc Nat! Acad Sci USA. 82: 5365-5369. -